NCT06382675View on ClinicalTrials.gov

Clinical Performance of the New Plasma Filter PX2 in TPE Treatments

NARecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Autoimmune Diseases
Interventions
DEVICE

Therapeutic Plasma Exchange (TPE) with the Plasma Filter PX2

230 evaluable TPE treatments will be documented in the study (with an average of 5-7 TPE treatments per patient this corresponds to approximately 46 patients)

Trial Locations (5)

13353

RECRUITING

Charité-Universitätsmedizin Berlin, Berlin

33098

RECRUITING

St. Vincenz Kliniken, Paderborn

38126

RECRUITING

Städtisches Klinikum Braunschweig, Braunschweig

63739

RECRUITING

Klinikum Aschaffenburg-Alzenau, Aschaffenburg

81377

RECRUITING

Klinikum der Ludwig-Maximilians-Universität München (LMU Klinikum), Munich

All Listed Sponsors
collaborator

KLIFO GmbH

UNKNOWN

lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY